423 (Ibuprofen and pseudoephedrine hydrochloride 200 mg / 30 mg)
Pill imprint 423 has been identified as Ibuprofen and pseudoephedrine hydrochloride 200 mg / 30 mg.
Ibuprofen/pseudoephedrine is used in the treatment of sinus symptoms and belongs to the drug class upper respiratory combinations. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Ibuprofen/pseudoephedrine 200 mg / 30 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 200 mg / 30 mg
- Elliptical / Oval
- Over the counter
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
- CSA Schedule:
- Not a controlled drug
- Ranbaxy Pharmaceuticals Inc.
More about ibuprofen/pseudoephedrine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.